id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
VA-2026-VBA-0067-20459,VA,VA-2026-VBA-0067,"Rescission of Interim Final Rule, Evaluative Rating: Impact of Medication (AS49)",Rule,,2026-02-27T05:00:00Z,2026,2,,,2026-03-09T16:56:15Z,2026-03940,0,0,09000064b91e31f5
VA-2026-VBA-0067-20360,VA,VA-2026-VBA-0067,2900-AS49(IF) Impact Analysis,Supporting & Related Material,,2026-02-26T05:00:00Z,2026,2,,,2026-02-27T02:53:23Z,,0,0,09000064b91df857
VA-2026-VBA-0067-0002,VA,VA-2026-VBA-0067,2900-AS49(IF) Impact Analysis,Supporting & Related Material,,2026-02-17T05:00:00Z,2026,2,,,2026-02-27T02:17:30Z,,0,1,09000064b91b3ea1
VA-2026-VBA-0067-0001,VA,VA-2026-VBA-0067,Evaluative Rating: Impact of Medication (AS49),Rule,,2026-02-17T05:00:00Z,2026,2,2026-02-17T05:00:00Z,2026-04-21T03:59:59Z,2026-03-14T09:00:10Z,2026-03068,1,0,09000064b91b1f6c